Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim - Cines, DB; Gernsheimer, T; Wasser, J (Int J Hematol, 2015)